Sterile manufacturing expert Symbiosis Pharmaceutical Services has further strengthened its North American presence with the appointment of another experienced US-based business development executive.
The Scotland-based contract manufacturing organisation (CMO) has engaged Rich Masino to promote its commercial interests on the West Coast of the US, which follows the recent appointment of Business Development Manager Derek Richards to oversee its commercial interests on the East Coast.
With more than 25 years’ experience in the biotechnology, life science, and pharmaceutical sectors, Masino has specialised in the pharmaceutical contract manufacturing sector over the last decade. Prior to that he held product development positions at Molecular Devices and Affymetrix and senior commercial roles at Stratagene (Agilent Technologies) and LIFE Technologies (Thermo Fisher).
He joins Symbiosis to support the CMO’s aim of developing its core aseptic manufacturing services in North America. Growing demand for these services has been fuelled by increased demand for small-scale biologic and small molecule sterile production capabilities to support a growing number of clinical trials globally.
Symbiosis specialises in sterile injectables and the aseptic manufacturing of drug products into vials. Its core manufacturing capability takes place within a purpose-built facility in Stirling, Scotland, designed for the manufacture and quick release of sterile drug products at clinical and niche market scale.